Email this page   Print-friendly version   Contact NINDS   Adobe Reader   Microsoft Word Viewer

The mission of the Office of Translational Research is to facilitate the preclinical discovery and development of new therapeutic interventions for neurological disorders by:

• Supporting preclinical development from the discovery of candidate therapeutics to Investigational New Drug (IND) and Investigational Device Exemption (IDE) applications to the FDA
• Support translational research projects and networks
• Supporting the design, implementation, and management of research infrastructure

Quick Links

Workshop Summary

• Gene Delivery to the Nervous System November 12, 2007
• All NINDS Workshop Summaries and Conference Proceedings

Office of Translational Research Funding Initiatives

• All Office of Translational Research funding initiatives

Office of Translational Research Program Staff

Scientific Staff	Research Area
Jill Heemskerk, Ph.D. Acting Director Director, The SMA Project	Preclinical therapeutic development, Medicinal Chemistry
David Jett, Ph.D. Program Director Director, CounterACT Network	Counterterrorism (CounterACT) Programs, Neurotoxicology
Yuan Liu, Ph.D. Program Director Chief, Office of International Activities	Neuroinformatics, Computational Neuroscience
Thomas Miller, Ph.D., M.B.A. Program Director	Preclinical Development of Therapeutics, Research Infrastructure
Mark Scheideler, Ph.D. Program Director	Roadmap Molecular Libraries
James Stables, MS Admin., R.Ph. Program Director Director, ASP	Anti-Convulsant Screening Program (ASP)
Stacey Chambers Program Analyst
Lydia Munger Program Analyst

Address

NINDS Office of Translational Research Neuroscience Center
6001 Executive Blvd Bethesda, Maryland 20892
For courier service only, use Rockville, Maryland 20852
Phone: (301) 496-1779